Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Lund, Johan
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
P
Nahi H
,
Celanovic M
,
Liu Q
,
Lund J
,
Peceliunas V
.
A Pilot, Exploratory, Randomized, Phase 2 Safety Study Evaluating Tumor Cell Mobilization and Apheresis Product Contamination in Patients Treated With Granulocyte Colony Stimulating Factor Alone or Plus Plerixafor.
Biol Blood Marrow Transplant. 2018.
PubMed
Google Scholar
M
Nahi H
,
Afram G
,
Uttervall K
,
Lockmer S
,
Tätting L
,
Gahrton G
,
Kashif M
,
Alici E
,
Stromberg O
,
Klimkowska M
, et al.
Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma.
Cancer Med. 2023.
PubMed
Google Scholar
I
Nahi H
,
Chrobok M
,
Gran C
,
Lund J
,
Gruber A
,
Gahrton G
,
Ljungman P
,
Wagner AKathleen
,
Alici E
.
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma.
PLoS One. 2019;14(2):e0211927.
PubMed
Google Scholar
Gagelmann N
,
Eikema D-J
,
Koster L
,
Netelenbos T
,
McDonald A
,
Stoppa A-M
,
Fenk R
,
Anagnostopoulos A
,
van Gorkom G
,
Deconinck E
, et al.
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study.
Eur J Haematol. 2023.
PubMed
Google Scholar